|
EPR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.254800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.755400E-01 |
| Normal-vs-Stage2 |
2.748200E-01 |
| Normal-vs-Stage3 |
7.772200E-01 |
| Normal-vs-Stage4 |
9.620600E-01 |
| Stage1-vs-Stage2 |
5.151900E-02 |
| Stage1-vs-Stage3 |
9.803800E-01 |
| Stage1-vs-Stage4 |
5.282000E-01 |
| Stage2-vs-Stage3 |
1.107610E-01 |
| Stage2-vs-Stage4 |
4.600400E-02 |
| Stage3-vs-Stage4 |
5.758400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.434200E-01 |
| Normal-vs-AfricanAmerican |
2.949000E-01 |
| Normal-vs-Asian |
5.937000E-01 |
| Caucasian-vs-AfricanAmerican |
1.509430E-01 |
| Caucasian-vs-Asian |
2.980800E-01 |
| AfricanAmerican-vs-Asian |
3.902400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.996000E-01 |
| Normal-vs-Female |
6.669400E-01 |
| Male-vs-Female |
4.103600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.738200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.088200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.965600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.359400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.718870E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.232800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.450600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.791500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.266430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.069800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.848200E-01 |
| Classical-VS-Follicular |
5.014300E-04 |
| Classical-VS-Other |
1.260160E-01 |
| Classical-VS-Normal |
9.319800E-01 |
| Tall-VS-Follicular |
2.612300E-02 |
| Tall-VS-Other |
1.892990E-01 |
| Tall-VS-Normal |
9.923400E-01 |
| Follicular-VS-Other |
7.543800E-01 |
| Follicular-VS-Normal |
1.748430E-01 |
| Other-VS-Normal |
3.445800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.392600E-01 |
| Normal-vs-N1 |
4.421800E-01 |
| N0-vs-N1 |
4.576600E-01 |
|
|
